Pranshu Sahgal

Pranshu Sahgal

Pranshu Sahgal, PhD
Executive Editor
Department of Medical Oncology, Dana-Farber Cancer Institute
Harvard Medical School, USA


Dr. Pranshu Sahgal is a postdoctoral fellow in medicine at Dana-Farber Cancer Institute and Harvard Medical School. Dr. Sahgal earned his master's in Biomedical Imaging and Ph.D. in 2018 in breast cancer biology, both from the University of Turku, Finland. During his doctoral studies, Dr. Sahgal explored the function of new proteins in regulating the trafficking of different plasma membrane receptors, hence influencing signaling and various cancer-related processes linked with these receptors in human cancer models. Dr. Sahgal has comprehensive experience in varied aspects of oncology, including cell and molecular biology of cancer, receptor trafficking, genomics, signaling, drug discovery/development, and molecular medicine. Currently, he is trying to find new mechanisms and drugs for the cancers of the gastrointestinal Tract (Gastric, Esophageal, and Colorectal Cancer) linked with Chromosomal Instability (CIN), tumor heterogeneity, DNA-Damage Response (DDR), and epigenetic regulation. Dr. Sahgal has been serving as a member of the reviewer and editorial board of over 40 scientific journals. For more details on Dr. Sahgal's work, visit:

Research Interest

Cancer cell proliferation, migration, and invasion; Cancer Signaling; DNA-Damage Response; Cancer Biomarkers; Drug discovery and development; Cancer Epigenetics; Cancer omics; Tumor Heterogeneity